
Omizac
Omizak is a medication that contains Omeprazole, a proton pump inhibitor (PPI) designed to reduce stomach acid production. It is commonly used to treat conditions such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and erosive esophagitis. By decreasing the amount of acid produced in the stomach, Omizak helps alleviate symptoms such as heartburn, difficulty swallowing, and persistent cough. The capsules are intended for oral use and should be taken as directed by a healthcare professional. Omizak is known for its effectiveness in promoting healing of the esophagus and preventing acid-related damage.Active substance:
OmeprazolePharmachologic effect:
Omizak is a proton pump inhibitor that decreases the amount of acid produced in the stomach, providing relief from acid-related conditions.Indications:
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease
- Zollinger-Ellison syndrome
- Erosive esophagitis
- Helicobacter pylori eradication (as part of combination therapy)
Contraindications:
- Hypersensitivity to omeprazole or any other components of the formulation
- Severe liver impairment
- Pregnancy and lactation unless clearly needed
Side effects:
In order of decreasing probability: Headache, Nausea, Diarrhea, Abdominal pain, Constipation, Flatulence, Dizziness, Rash
Dosing and Administration:
The recommended dose of Omizak for adults is 20 mg once daily before a meal. The duration of treatment varies depending on the condition being treated, typically ranging from 4 to 8 weeks. For Helicobacter pylori eradication, it is used in combination with antibiotics as prescribed by a healthcare professional.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Omizac
in Cyrillic : Омизак
SUBSTANCE
Omeprazole
DOSAGE FORM
capsules